Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB718 Engrossed / Bill

Filed 04/22/2021

                     
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED HOUSE AMENDME NT 
 TO 
ENGROSSED SENATE BILL NO . 718 By: McCortney of the Senate 
 
  and 
 
  Mize of the House 
 
 
 
 
 
An Act relating to allopathic medicine; amending 59 
O.S. 2011, Section 492, as amended by Section 1, 
Chapter 40, O.S.L. 2016 (59 O.S. Supp. 2020, Section 
492), which relates to definition of the practice of 
medicine; adding certain exclusion; and providing an 
effective date. 
 
 
 
  
AUTHORS:  Remove Representative Mize as principal House author and 
substitute with Representative McEntire 
 
 
AMENDMENT NO. 1.  Delete the title, enacting clause and entire bill 
and replace with: 
 
 
"An Act relating to pharmacy; amending 59 O.S. 2011, 
Section 353.18, as last amended by Section 4, 
Chapter 285, O.S.L. 2016 (59 O.S. Supp. 2020, 
Section 353.18), whic h relates to the sale, 
manufacturing or packaging of dangerous drugs; 
providing licensure exception; providing exception 
to pharmacy requirements for facilities distributing 
or dispensing dialysate or devices necessary for 
peritoneal dialysis; amending 59 O.S. 2011, Section 
353.24, as last amended by Section 6, Chapter 106, 
O.S.L. 2018 (59 O.S. Supp. 2020, Section 353.24), 
which relates to unlawful acts; providing certain 
construction; providing certification exception; and 
providing an effective date. 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
SECTION 1.     AMENDATORY     59 O.S. 2011, Section 353.18, as 
last amended by Section 4, Chapter 285, O.S.L. 2016 (59 O.S. Supp. 
2020, Section 353.18), is amended to read as follows: 
Section 353.18  A.  1.  It shall be unlawful for any person, 
including, but not limited to, Internet, website or online 
pharmacies, to sell at retail or to offer for sale, dangerous drugs, 
medicines, chemicals or poisons for the treatment of disease, 
excluding agricultural chemicals and drugs, or to accept 
prescriptions for same, without first procuring a license from the 
State Board of Pharmacy.  This licensure requirement applies whether 
such sale, offer for sale or acceptance of prescriptions occurs in 
this state, or such sale, offer for sale, or acceptance of 
prescription prescriptions occurs out of state and the dangerous 
drug, medicine, chemical or poison is to be delivered, distributed 
or dispensed to patients or customers in this state.  This licensure 
requirement shall not apply to the distribution or dispensing of 
dialysate or peritoneal dialysis devices to patients with end -stage 
renal disease (ESRD) consistent with subsection F of this section. 
2.  A pharmacy license shall be issued to such person a s the 
Board shall deem qualified upon evidence satisfactory to the Board 
that: 
a. the place for which the license is sought will be 
conducted in full compliance with the law and the 
rules of the Board,   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
b. the location and physical characteristics of the pl ace 
are reasonably consistent with the maintenance of 
professional surroundings and constitute no known 
danger to the public health and safety, 
c. the place will be under the management and control of 
a licensed pharmacist or pharmacist -in-charge who 
shall be licensed as a pharmacist in Oklahoma, and 
d. a licensed pharmacist shall be present and on duty at 
all business hours; provided, however, the provisions 
of this subparagraph shall not apply to hospital drug 
rooms. 
3. a. An application for an initial or renewal license 
issued pursuant to the provisions of this subsection 
shall: 
(1) be submitted to the Board in writing, 
(2) contain the name or names of persons owning the 
pharmacy, and 
(3) provide other such information deemed relevant by 
the Board. 
b. An application for an initial or renewal license shall 
be accompanied by a licensing fee not to exceed Three 
Hundred Dollars ($300.00) for each period of one (1) 
year.  Prior to opening for business, all applicants 
for an initial license or permit shall be in spected.    
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
An initial licensure applicant shall pay an inspection 
fee not to exceed Two Hundred Dollars ($200.00); 
provided, however, that no charge shall be made for 
the licensing of any Federal Veterans Hospital in the 
State of Oklahoma.  Non -resident pharmacies shall 
reimburse the Board for any actual expenses incurred 
for inspections. 
c. A license issued pursuant to the provisions of this 
subsection shall be valid for a period set by the 
Board and shall contain the name of the licensee and 
the address of the place at which such business shall 
be conducted. 
4.  A retail pharmacy that prepares sterile drugs shall obtain a 
pharmacy license, and shall also obtain a sterile compounding permit 
at a fee set by the Board, not to exceed Seventy -five Dollars 
($75.00).  Such pharmacy shall meet requirements set by the Board by 
rule for sterile compounding permits. 
5.  An outsourcing facility desiring to dispense prescriptions 
to patients must additionally license and meet the requirements of a 
pharmacy. 
B.  1.  It shall be unlawful for any person to manufacture, 
repackage, distribute, outsource, warehouse or be a third -party 
logistics provider of any dangerous drugs, medicines, medical gases, 
chemicals, or poisons for the treatment of disease, excluding   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
agricultural chemicals, without first procuring a license from the 
Board.  It shall be unlawful to sell or offer for sale at retail or 
wholesale dangerous drugs, medicines, medical gases, chemicals or 
poisons without first procuring a license from the Board.  This 
licensure requirement shall apply when the manufacturing, 
repackaging, distributing, outsourcing, warehousing, or provision of 
third-party logistics occurs in this state or out of state for 
delivery, distribution, or dispensing to patients or customers in 
this state. 
2.  A license shall be issued to such person as the Board shall 
deem qualified upon satisfactory evidence to the Board that: 
a. the place for which the license is sought will be 
conducted in full compliance with the laws of this 
state and the admini strative rules of the Board, 
b. the location and physical characteristics of the place 
of business are reasonably consistent with the 
maintenance of professional surroundings and 
constitute no known danger to public health and 
safety, 
c. the place shall be under the management and control of 
such persons as may be approved by the Board after a 
review and determination of the persons’ 
qualifications, and   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
d. an outsourcing facility shall designate in writing on 
a Board-approved form a person to serve as the 
pharmacist-in-charge who is a pharmacist licensed by 
the Board. 
3. a. An application for an initial or renewal license 
issued pursuant to the provisions of this subsection 
shall: 
(1) be submitted to the Board in writing, 
(2) contain the name or names of the owners or the 
applicants, and 
(3) provide such other information deemed relevant by 
the Board. 
b. An application for an initial or renewal license shall 
be accompanied by a licensing fee not to exceed Three 
Hundred Dollars ($300.00) for each period of one (1) 
year.  Prior to opening for business, all applicants 
for initial or renewal license shall be inspected.  An 
initial licensure applicant shall pay an inspection 
fee not to exceed Two Hundred Dollars ($200.00).  Non -
resident applicants shall reimburse t he Board for any 
actual expenses incurred for inspections. 
c. A license issued pursuant to the provisions of this 
subsection shall contain the name of the licensee and 
the address of the place at which such business shall   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
be conducted and shall be valid fo r a period of time 
set by the Board. 
C.  A licensee or permit holder who, pursuant to the provisions 
of this section, fails to complete an application for a renewal 
license or permit by the fifteenth day after the expiration of the 
license or permit shall pay a late fee to be fixed by the Board. 
D.  1.  The Board shall promulgate rules regarding the issuance 
and renewal of licenses and permits pursuant to the Oklahoma 
Pharmacy Act which shall include, but need not be limited to , 
provisions for new or renewa l application requirements for its 
licensees and permit holders.  Requirements for new and renewal 
applications may include, but need not be limited to, the following: 
a. type of ownership, whether individual, partnership, 
limited liability company or corp oration, 
b. names and addresses of principal owners or officers 
and their Social Security numbers, including 
applicant’s full name, all trade or business names 
used, full business address, telephone numbers, and 
email addresses, 
c. names of designated repr esentatives and facility 
managers and their Social Security numbers and dates 
of birth, 
d. evidence of a criminal background check and 
fingerprinting of the applicant, if a person, and all   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
of the applicant’s designated representatives and 
facility managers, 
e. a copy of the license from the applicant’s home state, 
and if applicable, from the federal government, 
f. bond requirements, and 
g. any other information deemed by the Board to be 
necessary to protect the public health and safety. 
2.  The Board shall be authorized to use an outside agency, such 
as the National Association of Boards of Pharmacy (NABP) or the 
Verified-Accredited Wholesale Distributors (VAWD), to accredit 
wholesale distributors and repackagers. 
E.  The Oklahoma Pharmacy Act shall not be c onstrued to prevent 
the sale of nonprescription drugs in original manufacturer packages 
by any merchant or dealer. 
F.  The Oklahoma Pharmacy Act shall not be construed to apply to 
a facility engaged in the distribution or dispensing to patients of 
dialysate or peritoneal dialysis devices necessary to perform home 
peritoneal dialysis, provided the following criteria are met: 
1.  The dialysate is comprised of dextrose or icodextrin; 
2.  The dialysate or peritoneal dialysis devices are approved or 
cleared by the United States Food and Drug Administration; 
3.  The dialysate or peritoneal dialysis devices are lawfully 
held by a manufacturer, or the manufacturer’s agent, who is properly 
licensed by the Board as a manufacturer, wholesaler or distributor;   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 9  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
4.  The dialysate or peritoneal dialysis devices are held and 
delivered in their original, sealed packaging from the manufacturing 
facility; 
5.  The dialysate or peritoneal dialysis devices are delivered 
only upon receipt of a physician’s prescription by a licensed 
pharmacy, and the transmittal of an order from the licensed pharmacy 
to the manufacturer or the manufacturer’s agent; and 
6.  The manufacturer or agent of the manufacturer delivers the 
dialysate or peritoneal dialysis devices directly to: 
a. a patient with ESRD or the patient’s designee for the 
patient’s self-administration of the dialysis therapy, 
or 
b. a health care provider or institution for 
administration or delivery of the dialysis therapy to 
the patient with ESRD. 
SECTION 2.     AMENDATORY     59 O.S. 2011, Section 353.24, as 
last amended by Section 6, Chapter 106, O.S.L. 2018 (59 O.S. Supp. 
2020, Section 353.24), is amended to read as follows: 
Section 353.24  A.  It shall be unlawful for any licensee or 
other person to: 
1.  Forge or increase the quantity of drug in any prescription, 
or to present a prescription bearing forged, fictitious or altered 
information or to possess any drug secured by such forged, 
fictitious or altered prescription;   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 10  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  Sell, offer for sale, barter or give a way any unused 
quantity of drugs obtained by prescription, except through a program 
pursuant to the Utilization of Unused Prescription Medications Act 
or as otherwise provided by the State Board of Pharmacy; 
3.  Sell, offer for sale, barter or give away an y drugs damaged 
by fire, water, or other causes without first obtaining the written 
approval of the Board or the State Department of Health; 
4.  No person, firm or business establishment shall offer to the 
public, in any manner, their services as a “pick -up station” or 
intermediary for the purpose of having prescriptions filled or 
delivered, whether for profit or gratuitously.  Nor may the owner of 
any pharmacy or drug store authorize any person, firm or business 
establishment to act for them in this manner with these exceptions: 
a. patient-specific filled prescriptions may be delivered 
or shipped to a prescriber’s clinic for pick -up by 
those patients whom the prescriber has individually 
determined and documented do not have a permanent or 
secure mailing address, 
b. patient-specific filled prescriptions for drugs which 
require special handling written by a prescriber may 
be delivered or shipped to the prescriber’s clinic for 
administration or pick -up at the prescriber’s office, 
c. patient-specific filled pres criptions, including 
sterile compounded drugs, may be delivered or shipped   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 11  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
to a prescriber’s clinic where they shall be 
administered, 
d. patient-specific filled prescriptions for patients 
with End Stage Renal Disease end-stage renal disease 
(ESRD) may be delivered or shipped to a prescriber’s 
clinic for administration or final delivery to the 
patient, 
e. patient-specific filled prescriptions for 
radiopharmaceuticals may be delivered or shipped to a 
prescriber’s clinic for administration or pick -up, or 
f. patient-specific filled prescriptions may be delivered 
or shipped by an Indian Health Services (IHS) or 
federally recognized tribal health organization 
operating under the IHS in the delivery of the 
prescriptions to a pharmacy operated by the IHS or a 
federally recognized tribal health organization for 
pick-up by an IHS or tribal patient. 
However, nothing in this paragraph shall prevent a pharmacist or 
an employee of the pharmacy from personally receiving a prescription 
or delivering a legally filled prescrip tion to a residence, office 
or place of employment of the patient for whom the prescription was 
written.  Provided further, the provisions of this paragraph shall 
not apply to any Department of Mental Health and Substance Abuse 
Services employee or any per son whose facility contracts with the   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 12  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Department of Mental Health and Substance Abuse Services whose 
possession of any dangerous drug, as defined in Section 353.1 of 
this title, is for the purpose of delivery of a mental health 
consumer’s medicine to the c onsumer’s home or residence.  Nothing in 
this paragraph shall prevent veterinary prescription drugs from 
being shipped directly from an Oklahoma licensed wholesaler or 
distributor registered with the Oklahoma Board of Veterinary Medical 
Examiners to a client; provided, such drugs may be dispensed only on 
prescription of a licensed veterinarian and only when an existing 
veterinary-client-patient relationship exists .  Nothing in this 
paragraph shall prevent dialysate and peritoneal dialysis devices 
from being shipped directly from an Oklahoma licensed manufacturer, 
wholesaler or distributor to an ESRD patient or patient’s designee, 
consistent with subsection F of Section 353.18 of this title ; 
5.  Sell, offer for sale or barter or buy any professional 
samples except through a program pursuant to the Utilization of 
Unused Prescription Medications Act; 
6.  Refuse to permit or otherwise prevent members of the Board 
or such representatives thereof from entering and inspecting any and 
all places, including premises, vehicles, equipment, contents, and 
records, where drugs, medicine, chemicals or poisons are stored, 
sold, vended, given away, compounded, dispensed, repackaged, 
transported, or manufactured;   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 13  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
7.  Interfere, refuse to participate in, impede or otherwise 
obstruct any inspection, investigation or disciplinary proceeding 
authorized by the Oklahoma Pharmacy Act; 
8.  Possess dangerous drugs without a valid prescription or a 
valid license to possess such drugs; provided, however, this 
provision shall not apply to a ny Department of Mental Health and 
Substance Abuse Services employee or any person whose facility 
contracts with the Department of Mental Health and Substance Abuse 
Services whose possession of any dangerous drug, as defined in 
Section 353.1 of this title, is for the purpose of delivery of a 
mental health consumer’s medicine to the consumer’s home or 
residence; 
9.  Fail to establish and maintain effective controls against 
the diversion of drugs for any other purpose than legitimate 
medical, scientific or in dustrial uses as provided by state, federal 
and local law; 
10.  Fail to have a written drug diversion detection and 
prevention policy; 
11.  Possess, sell, offer for sale, barter or give away any 
quantity of dangerous drugs not listed as a scheduled drug pu rsuant 
to Sections 2-201 through 2-212 of Title 63 of the Oklahoma Statutes 
when obtained by prescription bearing forged, fictitious or altered 
information.   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 14  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
a. A first violation of this section shall constitute a 
misdemeanor and upon conviction shall be pu nishable by 
imprisonment in the county jail for a term not more 
than one (1) year and a fine in an amount not more 
than One Thousand Dollars ($1,000.00). 
b. A second violation of this section shall constitute a 
felony and upon conviction shall be punishabl e by 
imprisonment in the Department of Corrections for a 
term not exceeding five (5) years and a fine in an 
amount not more than Two Thousand Dollars ($2,000.00); 
12.  Violate a Board order or agreed order; 
13.  Compromise the security of licensure examina tion materials; 
or 
14.  Fail to notify the Board, in writing, within ten (10) days 
of a licensee or permit holder’s address change. 
B.  1.  It shall be unlawful for any person other than a 
licensed pharmacist or physician to certify a prescription before 
delivery to the patient or the patient’s representative or 
caregiver.  Dialysate and peritoneal dialysis devices supplied 
pursuant to the provisions of subsection F of Section 353.18 of this 
title shall not be required to be certified by a pharmacist prior to 
being supplied by a manufacturer, wholesaler or distributor.   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 15  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
2.  It shall be unlawful for any person to institute or manage a 
pharmacy unless such person is a licensed pharmacist or has placed a 
licensed pharmacist in charge of such pharmacy. 
3.  No licensed pharmacist shall manage, supervise or be in 
charge of more than one pharmacy. 
4.  No pharmacist being requested to sell, furnish or compound 
any drug, medicine, chemical or other pharmaceutical preparation, by 
prescription or otherwise, shall substit ute or cause to be 
substituted for it, without authority of the prescriber or 
purchaser, any like drug, medicine, chemical or pharmaceutical 
preparation. 
5.  No pharmacy, pharmacist -in-charge or other person shall 
permit the practice of pharmacy except by a licensed pharmacist or 
assistant pharmacist. 
6.  No person shall subvert the authority of the pharmacist -in-
charge of the pharmacy by impeding the management of the 
prescription department to act in compliance with federal and state 
law. 
C.  1.  It shall be unlawful for a pharmacy to resell dangerous 
drugs to any wholesale distributor. 
2.  It shall be unlawful for a wholesale distributor to purchase 
drugs from a pharmacy. 
SECTION 3.  This act shall become effective November 1, 2021. " 
   
 
ENGR. H. A. to ENGR. S. B. NO. 718 	Page 16  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Passed the House of Representatives the 21st day of April, 2021. 
 
 
 
 
  
Presiding Officer of the House of 
 	Representatives 
 
 
Passed the Senate the ____ day of _____, 2021. 
 
 
 
 
  
Presiding Officer of the Senate 
   
 
ENGR. S. B. NO. 718 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
ENGROSSED SENATE 
BILL NO. 718 	By: McCortney of the Senate 
 
  and 
 
  Mize of the House 
 
 
 
 
An Act relating to allopathic medicine; amending 59 
O.S. 2011, Section 492, as amended by Section 1, 
Chapter 40, O.S.L. 2016 (59 O.S. Supp. 2020, Section 
492), which relates to definition of the practice of 
medicine; adding certain exclusion; and providing an 
effective date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 4.     AMENDATORY     59 O.S. 2011, Section 492, as 
amended by Section 1, Chapter 40, O.S.L. 2016 (59 O.S. Sup p. 2020, 
Section 492), is amended to read as follows: 
Section 492.  A.  Every person shall be regarded as practicing 
allopathic medicine within the meaning and provisions of this act 
the Oklahoma Allopathic Medical and Surgical Licensure and 
Supervision Act, who shall append to his or her name the letters 
“M.D.”, “Physician” or any other title, letters or designation which 
represent that such person is a physician, or who shall for a fee or 
any form of compensation diagnose and/or treat disease, injury or 
deformity of persons in this state by any allopathic legend drugs, 
surgery, manual, or mechanical treatment unless otherwise authorized 
by law.   
 
ENGR. S. B. NO. 718 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
B.  A hospital or related institution as such terms are defined 
in Section 1-701 of Title 63 of the Oklahoma Stat utes, which has the 
principal purpose or function of providing hospital or medical care, 
including but not limited to any corporation, association, trust , or 
other organization organized and operated for such purpose, may 
employ one or more persons who are duly licensed to practice 
medicine in this state without being regarded as itself practicing 
medicine within the meaning and provisions of this section.  The 
employment by the hospital or related institution of any person who 
is duly licensed to practice medicine in this state shall not, in 
and of itself, be considered as an act of unprofessional conduct by 
the person so employed.  Nothing provided herein shall eliminate, 
limit, or restrict the liability for any act or failure to act of 
any hospital, any hospital’s employees, or persons duly licensed to 
practice medicine. 
C.  The definition of the practice of medicine and surgery shall 
include, but is not limited to: 
1.  Advertising, holding out to the public , or representing in 
any manner that one is autho rized to practice medicine and surgery 
in this state; 
2.  Any offer or attempt to prescribe, order, give, or 
administer any drug or medicine and surgery for the use of any other 
person, except as otherwise authorized by law;   
 
ENGR. S. B. NO. 718 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
3. a. any offer or attempt, exc ept as otherwise authorized 
by law, to prevent, diagnose, correct , or treat in any 
manner or by any means, methods, devises , or 
instrumentalities except for manual manipulation any 
disease, illness, pain, wound, fracture, infirmity, 
defect, or abnormal physical or mental condition of 
any person, including the management of pregnancy and 
parturition, except as otherwise authorized by law, 
b. except as provided in subsection D of this section, 
performance by a person within or outside of this 
state, through an ongoing regular arrangement, of 
diagnostic or treatment services , including, but not 
limited to, stroke prevention and treatment, through 
electronic communications for any patient whose 
condition is being diagnosed or treated within this 
state by a physician duly licensed and practicing in 
this state.  A person who performs any of the 
functions covered by this subparagraph submits himself 
or herself to the jurisdiction of the courts of this 
state for the purposes of any cause of action 
resulting from the functions performed, and 
c. nothing in the Oklahoma Allopathic Medical and 
Surgical Licensure and Supervision Act shall be 
construed to affect or give jurisdiction to the Board   
 
ENGR. S. B. NO. 718 	Page 4  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
over any person other than medical doctors or persons 
holding themselves out as medical doctors; 
4.  Any offer or attempt to perform any surgical operation upon 
any person, except as otherwise authorized by law; and 
5.  The use of the title Doctor of Medicine, Physician, Surgeon, 
Physician and Surgeon, Dr., M.D. or any combination th ereof in the 
conduct of any occupation or profession pertaining to the 
prevention, diagnosis, or treatment of human disease or condition 
unless, where appropriate, such a designation additionally contains 
the description of another branch of the healing ar ts for which one 
holds a valid license in this state. 
D.  The practice of medicine and surgery, as defined in this 
section, shall not include: 
1.  A student while engaged in training in a medical school 
approved by the Board or while engaged in graduate me dical training 
under the supervision of the medical staff of a hospital or other 
health care facility approved by the state medical board for such 
training, except that a student engaged in graduate medical training 
shall hold a license issued by the Board for such training; 
2.  Any person who provides medical treatment in cases of 
emergency where no fee or other consideration is contemplated, 
charged or received; 
3.  A commissioned medical officer of the armed forces of the 
United States or medical officer of the United States Public Health   
 
ENGR. S. B. NO. 718 	Page 5  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
Service or the Department of Veterans Affairs of the United States 
in the discharge of official duties and/or within federally 
controlled facilities; and provided that such person shall be fully 
licensed to practice medi cine and surgery in one or more 
jurisdictions of the United States; provided further that such 
person who holds a medical license in this state shall be subject to 
the provisions of the Oklahoma Allopathic Medical and Surgical 
Licensure and Supervision Act ; 
4.  Any person licensed under any other act when properly 
practicing in the healing art for which that person is duly 
licensed; 
5.  The practice of those who endeavor to prevent or cure 
disease or suffering by spiritual means or prayer; 
6.  Any person administering a domestic or family remedy to a 
member of such person’s own family; 
7.  Any person licensed to practice medicine and surgery in 
another state or territory of the United States who renders 
emergency medical treatment or briefly provides critica l medical 
service at the specific lawful direction of a medical institution or 
federal agency that assumes full responsibility for that treatment 
or service and is approved by the Board; 
8.  Any person who is licensed to practice medicine and surgery 
in another state or territory of the United States whose sole 
purpose and activity is limited to brief actual consultation with a   
 
ENGR. S. B. NO. 718 	Page 6  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
specific physician who is licensed to practice medicine and surgery 
by the Board, other than a person with a special or restricted 
license; or 
9.  Any person who is licensed to practice medicine and surgery 
in another state or territory of the United States who engages in 
consultation through telehealth with a patient physically located in 
this state for the sole purpose of providing an expert second 
opinion; or 
10. The practice of any other person as licensed by appropriate 
agencies of this state, provided that such duties are consistent 
with the accepted standards of the person’s profession and the 
person does not represent himself or herself as a Doctor of 
Medicine, Physician, Surgeon, Physician and Surgeon, Dr., M.D. , or 
any combination thereof. 
E.  Nothing in the Oklahoma Allopathic Medical and Surgical 
Licensure and Supervision Act shall prohibit: 
1.  The service rendered by a ph ysician’s unlicensed trained 
assistant, if such service is rendered under the supervision and 
control of a licensed physician pursuant to Board rules, provided 
such rules are not in conflict with the provisions of any other 
healing arts licensure act or ru les promulgated pursuant to such 
act; or 
2.  The service of any other person duly licensed or certified 
by the state to practice the healing arts.   
 
ENGR. S. B. NO. 718 	Page 7  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
F.  Nothing in the Oklahoma Allopathic Medical and Surgical 
Licensure and Supervision Act shall prohibit serv ices rendered by 
any person not licensed by the Board and practicing any 
nonallopathic healing practice. 
G.  Nothing in the Oklahoma Allopathic Medical and Surgical 
Licensure and Supervision Act shall be construed as to require a 
physician to secure a Main tenance of Certification (MOC) as a 
condition of licensure, reimbursement, employment or admitting 
privileges at a hospital in this state.  For the purposes of this 
subsection, “Maintenance of Certification (MOC)” shall mean a 
continuing education program measuring core competencies in the 
practice of medicine and surgery and approved by a nationally -
recognized accrediting organization. 
SECTION 5.  This act shall become effective November 1, 2021. 
Passed the Senate the 10th day of March, 2021. 
 
 
  
 	Presiding Officer of the Senate 
 
 
Passed the House of Representatives the ____ day of __________, 
2021. 
 
 
  
 	Presiding Officer of the House 
 	of Representatives 
   
 
ENGR. S. B. NO. 718 	Page 8  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24